Previous studies in somatotroph adenomas suggest that attenuated E-cadherin expression, which is lost in the epithelial mesenchymal transition (EMT), is associated with reduced responsiveness to SA treatment as well as increased tumor size and invasiveness [7], [8]. The gene discussed is CDH1; the disease is growth hormone-secreting pituitary adenoma.